Nova Organic Valuation
Is NV-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NV-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate NV-R's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate NV-R's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NV-R?
Other financial metrics that can be useful for relative valuation.
What is NV-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿800.62m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.5x |
Enterprise Value/EBITDA | -8.8x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does NV-R's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 4.3x | ||
DOD DOD Biotech | 1.7x | n/a | ฿1.2b |
TNR Thai Nippon Rubber Industry Public | 1.5x | n/a | ฿2.9b |
APCO Asian Phytoceuticals | 10x | n/a | ฿2.9b |
KISS Rojukiss International | 4x | 10.8% | ฿3.9b |
NV-R Nova Organic | 1.3x | n/a | ฿800.6m |
Price-To-Sales vs Peers: NV-R is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (4.3x).
Price to Earnings Ratio vs Industry
How does NV-R's PE Ratio compare vs other companies in the Asian Personal Products Industry?
Price-To-Sales vs Industry: NV-R is good value based on its Price-To-Sales Ratio (1.3x) compared to the Asian Personal Products industry average (1.8x).
Price to Sales Ratio vs Fair Ratio
What is NV-R's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.3x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate NV-R's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.